| 000 | 01221 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513184121.0 | ||
| 264 | 0 | _c19991022 | |
| 008 | 199910s 0 0 spa d | ||
| 022 | _a0025-7753 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarvajal García-Pando, A | |
| 245 | 0 | 0 |
_a[Ticlopidine and hepatic adverse reactions. Data from the Spanish drug surveillance system]. _h[electronic resource] |
| 260 |
_bMedicina clinica _cApr 1999 |
||
| 300 |
_a557-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSpain _xepidemiology |
| 650 | 0 | 4 |
_aTiclopidine _xadverse effects |
| 700 | 1 | _aGarcía Ortega, P | |
| 700 | 1 | _aRueda de Castro, A M | |
| 700 | 1 | _aGarcía del Pozo, J | |
| 773 | 0 |
_tMedicina clinica _gvol. 112 _gno. 14 _gp. 557-8 |
|
| 999 |
_c10321792 _d10321792 |
||